Emmanuel Papadakis

Stock Analyst at Deutsche Bank

(1.47)
# 3,209
Out of 4,784 analysts
41
Total ratings
47.37%
Success rate
-0.38%
Average return

Stocks Rated by Emmanuel Papadakis

BioNTech SE
Sep 19, 2024
Maintains: Buy
Price Target: $95$150
Current: $94.95
Upside: +57.98%
Moderna
Aug 6, 2024
Upgrades: Hold
Price Target: $85$80
Current: $31.12
Upside: +157.07%
Grifols
Mar 12, 2024
Downgrades: Sell
Price Target: n/a
Current: $7.27
Upside: -
AstraZeneca
Feb 8, 2024
Downgrades: Hold
Price Target: n/a
Current: $73.79
Upside: -
Alvotech
Mar 7, 2023
Maintains: Hold
Price Target: $8$12
Current: $9.55
Upside: +25.65%
Sanofi
Aug 12, 2022
Upgrades: Hold
Price Target: n/a
Current: $55.82
Upside: -
Novo Nordisk
Mar 16, 2022
Upgrades: Buy
Price Target: n/a
Current: $69.30
Upside: -
CureVac
Oct 22, 2021
Initiates: Hold
Price Target: $35
Current: $2.98
Upside: +1,074.50%
Novartis AG
Sep 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $112.57
Upside: -
argenx SE
Jul 23, 2021
Initiates: Hold
Price Target: n/a
Current: $589.15
Upside: -
Downgrades: Sell
Price Target: n/a
Current: $38.74
Upside: -